107 related articles for article (PubMed ID: 7629655)
21. Evaluation of furosemide-loaded alginate microspheres prepared by ionotropic external gelation technique.
Das MK; Senapati PC
Acta Pol Pharm; 2007; 64(3):253-62. PubMed ID: 17695149
[TBL] [Abstract][Full Text] [Related]
22. Extended release of high pI proteins from alginate microspheres via a novel encapsulation technique.
Wells LA; Sheardown H
Eur J Pharm Biopharm; 2007 Mar; 65(3):329-35. PubMed ID: 17156984
[TBL] [Abstract][Full Text] [Related]
23. Effect of cellulose derivatives on alginate microspheres prepared by emulsification.
Chan LW; Heng PW; Wan LS
J Microencapsul; 1997; 14(5):545-55. PubMed ID: 9292431
[TBL] [Abstract][Full Text] [Related]
24. Preparation and characterization of alginate-gelatin microencapsulated Bacillus subtilis SL-13 by emulsification/internal gelation.
Tu L; He Y; Yang H; Wu Z; Yi L
J Biomater Sci Polym Ed; 2015; 26(12):735-49. PubMed ID: 26159659
[TBL] [Abstract][Full Text] [Related]
25. Immobilization and bioactivity of glucose oxidase in hydrogel microspheres formulated by an emulsification-internal gelation-adsorption-polyelectrolyte coating method.
Liu Q; Rauth AM; Wu XY
Int J Pharm; 2007 Jul; 339(1-2):148-56. PubMed ID: 17398046
[TBL] [Abstract][Full Text] [Related]
26. Development of serratiopeptidase and metronidazole based alginate microspheres for wound healing.
Rath G; Johal ES; Goyal AK
Artif Cells Blood Substit Immobil Biotechnol; 2011 Feb; 39(1):44-50. PubMed ID: 20553201
[TBL] [Abstract][Full Text] [Related]
27. Alginate microspheres prepared by internal gelation: development and effect on insulin stability.
Silva CM; Ribeiro AJ; Figueiredo IV; Gonçalves AR; Veiga F
Int J Pharm; 2006 Mar; 311(1-2):1-10. PubMed ID: 16442757
[TBL] [Abstract][Full Text] [Related]
28. Microencapsulation using emulsification/solvent evaporation: an overview of techniques and applications.
Watts PJ; Davies MC; Melia CD
Crit Rev Ther Drug Carrier Syst; 1990; 7(3):235-59. PubMed ID: 2073688
[TBL] [Abstract][Full Text] [Related]
29. Inhalable, bioresponsive microparticles for targeted drug delivery in the lungs.
Sivadas N; Cryan SA
J Pharm Pharmacol; 2011 Mar; 63(3):369-75. PubMed ID: 21749384
[TBL] [Abstract][Full Text] [Related]
30. Microencapsulation of a hydrophilic model molecule through vibration nozzle and emulsion phase inversion technologies.
Dorati R; Genta I; Modena T; Conti B
J Microencapsul; 2013; 30(6):559-70. PubMed ID: 23570546
[TBL] [Abstract][Full Text] [Related]
31. Urease loaded alginate microspheres for blood purification.
Ciofani G; Cascone MG; Serino LP; Lazzeri L
J Microencapsul; 2008 Dec; 25(8):569-76. PubMed ID: 18465293
[TBL] [Abstract][Full Text] [Related]
32. Toxicity and gut associated lymphoid tissue translocation of polymyxin B orally administered by alginate/chitosan microparticles in rats.
Coppi G; Bondi M; Coppi A; Rossi T; Sergi S; Iannuccelli V
J Pharm Pharmacol; 2008 Jan; 60(1):21-6. PubMed ID: 18088501
[TBL] [Abstract][Full Text] [Related]
33. Shape-controlled production of biodegradable calcium alginate gel microparticles using a novel microfluidic device.
Liu K; Ding HJ; Liu J; Chen Y; Zhao XZ
Langmuir; 2006 Oct; 22(22):9453-7. PubMed ID: 17042568
[TBL] [Abstract][Full Text] [Related]
34. Preparation and in vitro evaluation of mucoadhesive properties of alginate/chitosan microparticles containing prednisolone.
Wittaya-areekul S; Kruenate J; Prahsarn C
Int J Pharm; 2006 Apr; 312(1-2):113-8. PubMed ID: 16490331
[TBL] [Abstract][Full Text] [Related]
35. Alginate microparticles as novel carrier for oral insulin delivery.
Reis CP; Ribeiro AJ; Neufeld RJ; Veiga F
Biotechnol Bioeng; 2007 Apr; 96(5):977-89. PubMed ID: 17001630
[TBL] [Abstract][Full Text] [Related]
36. Coating alginate microspheres with a serum albumin-alginate membrane: application to the encapsulation of a peptide.
Hurteaux R; Edwards-Lévy F; Laurent-Maquin D; Lévy MC
Eur J Pharm Sci; 2005 Feb; 24(2-3):187-97. PubMed ID: 15661490
[TBL] [Abstract][Full Text] [Related]
37. Alginate-poloxamer microparticles for controlled drug delivery to mucosal tissue.
Moebus K; Siepmann J; Bodmeier R
Eur J Pharm Biopharm; 2009 May; 72(1):42-53. PubMed ID: 19126428
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of sodium alginate as drug release modifier in matrix tablets.
Liew CV; Chan LW; Ching AL; Heng PW
Int J Pharm; 2006 Feb; 309(1-2):25-37. PubMed ID: 16364576
[TBL] [Abstract][Full Text] [Related]
39. Preparation and improvement of release behavior of chitosan microspheres containing insulin.
Wang LY; Gu YH; Su ZG; Ma GH
Int J Pharm; 2006 Mar; 311(1-2):187-95. PubMed ID: 16436319
[TBL] [Abstract][Full Text] [Related]
40. [Preparation of uniform-sized chitosan microspheres and application as carriers for protein drugs].
Gu YH; Wang LY; Tan TW; Ma GH
Sheng Wu Gong Cheng Xue Bao; 2006 Jan; 22(1):150-5. PubMed ID: 16572856
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
